Aljian Capital Management LLC Acquires New Stake in Abbott Laboratories (NYSE:ABT)
MarketBeat
Aljian Capital Management LLC bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 3,115 shares of the healthcare product maker's stock, valued at approximately $413,000. Severa
NYSE:ABT